These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34407914)

  • 1. Wound healing and dermal regeneration in severe burn patients treated with NovoSorb® Biodegradable Temporising Matrix: A prospective clinical study.
    Lo CH; Brown JN; Dantzer EJG; Maitz PKM; Vandervord JG; Wagstaff MJD; Barker TM; Cleland H
    Burns; 2022 May; 48(3):529-538. PubMed ID: 34407914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of 'stacked' dermal template: Biodegradable temporising matrix to close a large myelomeningocele defect in a newborn.
    Hasham S; O'Boyle C; Alexander S
    Scars Burn Heal; 2024; 10():20595131241270220. PubMed ID: 39234573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with NovoSorb® Biodegradable Temporising Matrix in reconstruction of complex wounds.
    Li H; Lim P; Stanley E; Lee G; Lin S; Neoh D; Liew J; Ng SK
    ANZ J Surg; 2021 Sep; 91(9):1744-1750. PubMed ID: 34085755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A consecutive case series of defects reconstructed using NovoSorb
    Solanki NS; York B; Gao Y; Baker P; Wong She RB
    J Plast Reconstr Aesthet Surg; 2020 Oct; 73(10):1845-1853. PubMed ID: 32563668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artificial dermal templates: A comparative study of NovoSorb™ Biodegradable Temporising Matrix (BTM) and Integra(®) Dermal Regeneration Template (DRT).
    Cheshire PA; Herson MR; Cleland H; Akbarzadeh S
    Burns; 2016 Aug; 42(5):1088-1096. PubMed ID: 27222383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novosorb® Biodegradable Temporising Matrix (BTM) and its Applications.
    Lim P; Li H; Ng S
    Surg Technol Int; 2023 Sep; 42():47-52. PubMed ID: 37053370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodegradable temporising matrix: use of negative pressure wound therapy shows a significantly higher success rate.
    Austin CL; Draper B; Larson KW; Thompson SJ
    J Wound Care; 2023 Mar; 32(3):159-166. PubMed ID: 36930194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NovoSorb® Biodegradable Temporising Matrix (BTM): What we learned from the first 300 consecutive cases.
    Tapking C; Thomas BF; Hundeshagen G; Haug VFM; Gazyakan E; Bliesener B; Bigdeli AK; Kneser U; Vollbach FH
    J Plast Reconstr Aesthet Surg; 2024 May; 92():190-197. PubMed ID: 38547552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of NovoSorb biodegradable temporising matrix in wound management: a literature review and case series.
    Kidd T; Kolaityte V; Bajaj K; Wallace D; Izadi D; Bechar J
    J Wound Care; 2023 Aug; 32(8):470-478. PubMed ID: 37572341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of a Full-Thickness Burn Injury With NovoSorb Biodegradable Temporizing Matrix and RECELL Autologous Skin Cell Suspension: A Case Series.
    Larson KW; Austin CL; Thompson SJ
    J Burn Care Res; 2020 Jan; 41(1):215-219. PubMed ID: 31765469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes and resource utilisation in patients with major burns treated with NovoSorb® BTM.
    Betar N; Maher D; Wheatley L; Barker T; Brown J
    Burns; 2023 Nov; 49(7):1663-1669. PubMed ID: 37344307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Split skin graft application over an integrating, biodegradable temporizing polymer matrix: immediate and delayed.
    Greenwood JE; Dearman BL
    J Burn Care Res; 2012; 33(1):7-19. PubMed ID: 22079917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NovoSorb® Biodegradable Temporizing Matrix: a novel approach for treatment of extremity avulsion injuries in children.
    Najem S; Fattouh M; Wintges K; Schoof B; Koerner M; Reinshagen K; Koenigs I
    Eur J Trauma Emerg Surg; 2024 Aug; 50(4):1807-1815. PubMed ID: 38668874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of Suprathel(®) in deep dermal burns: first results of a prospective study.
    Keck M; Selig HF; Lumenta DB; Kamolz LP; Mittlböck M; Frey M
    Burns; 2012 May; 38(3):388-95. PubMed ID: 22078803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategic Use of Biodegradable Temporizing Matrix (BTM) in Wound Healing: A Case Series in Asian Patients.
    Chen AC; Lin TW; Chang KC; Chang DH
    J Funct Biomater; 2024 May; 15(5):. PubMed ID: 38786647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term scarring outcomes and safety of patients treated with NovoSorb
    Lo CH; Wagstaff MJD; Barker TM; Damkat-Thomas L; Salerno S; Holden D; Concannon E; Heath K; Coghlan P; Cleland H
    JPRAS Open; 2023 Sep; 37():42-51. PubMed ID: 37360978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Necrotizing Fasciitis With NovoSorb Biodegradable Temporizing Matrix and RECELL Autologous Skin Cell Suspension: A Case Series.
    Austin CL; Sodade OE; Harrison B; Causa K
    J Burn Care Res; 2024 Mar; 45(2):528-532. PubMed ID: 38085950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of biodegradable temporizing matrix vs collagen-chondroitin silicone bilayer dermal regeneration substitutes in soft tissue wound healing: a retrospective analysis.
    Wu SS; Wells M; Ascha M; Gatherwright J; Chepla K
    Wounds; 2022 Apr; 34(4):106-115. PubMed ID: 35452408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Use of Dermal Substitute in Deep Burns of Functional/Mobile Anatomic Areas at Acute Phase After Early Excision and Subsequent Skin Autografting: Dermal Substitute Prevents Functional Limitations.
    Gurbuz K; Demir M; Das K
    J Burn Care Res; 2020 Sep; 41(5):1079-1083. PubMed ID: 32198511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Application of a Synthetic Biodegradable Temporizing Matrix in Extensive Burn Injury: A Unicenter Experience of 175 Cases.
    Tapking C; Panayi AC; Hundeshagen G; Thomas BF; Gazyakan E; Bliesener B; Bigdeli AK; Kneser U; Vollbach FH
    J Clin Med; 2024 May; 13(9):. PubMed ID: 38731190
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.